Reshaping Biotechnology’s Financing Relay Race

Biotech’s current funding crisis is unlike any previous funding challenge the sector has faced. In the past, funding droughts were largely driven by investor sentiment toward the biotech industry. When investors were bullish about the sector’s prospects — for instance, […]

Read More

Comparative Effectiveness: Tools, Not Rules

The topic of comparative effectiveness research (CER) took off with a bang as the Obama Administration boosted funding for the activity in its January stimulus package by $1.1 billion, as reported in last month’s issue. Commentary from Washington officials and […]

Read More

Fine-Tuning Specialty Distribution

Specialty pharmaceuticals are the fastest growing segment of drugs in healthcare in the United States. With projected US growth of 178% from 2003-2010, the dollar value of available specialty drugs will surpass that of generic prescription medications.[1] Sales of specialty […]

Read More

Momentum Builds in Vaccine Development

Historians often cite the early 1980s as the dawn of biotechnology but in fact vaccines – arguably medicine’s greatest achievements – existed two hundred years earlier. Vaccines may be undergoing a “golden age,” according to Rino Rappuoli, PhD, who heads […]

Read More

Economic Considerations For REMS

The Food and Drug Administration Amendments Act of 2007 (FDAAA) establishes broader authority for the agency in a variety of ways, perhaps none more game-changing than the authority to require a Risk Evaluation and Mitigation Strategy (REMS) for new and […]

Read More

HCPC 2008 Compliance Packaging Winners Announced

The Healthcare Compliance Packaging Council (HCPC; Falls Church, VA) has selected the winners of its annual competition for innovative packaging that enhances patient compliance. They are: 2008 Compliance Package of the Year: Prempro Starter Kit by Wyeth Pharmaceuticals First Runner-Up: […]

Read More

Data Virtualization Comes to Biopharma

As much as the billions of pills, capsules and injections that the biopharma industry produces, it generates even more data. Clinical trials generate terabytes of data; sales operations and marketing research assemble vast pools of prescriber and patient data; commercial […]

Read More